PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.30%
Positive revenue growth while ADI is negative. John Neff might see a notable competitive edge here.
8.98%
Positive gross profit growth while ADI is negative. John Neff would see a clear operational edge over the competitor.
18.97%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
18.97%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
18.22%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
16.67%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
20.00%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.35%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.07%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
98.97%
Dividend growth above 1.5x ADI's 11.69%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
62.09%
OCF growth above 1.5x ADI's 14.64%. David Dodd would confirm a clear edge in underlying cash generation.
93.07%
FCF growth above 1.5x ADI's 16.75%. David Dodd would verify if the firm’s strategic investments yield superior returns.
42.64%
10Y revenue/share CAGR under 50% of ADI's 138.26%. Michael Burry would suspect a lasting competitive disadvantage.
109.40%
5Y revenue/share CAGR 1.25-1.5x ADI's 78.82%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
29.69%
3Y revenue/share CAGR above 1.5x ADI's 12.03%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
58.50%
10Y OCF/share CAGR under 50% of ADI's 221.10%. Michael Burry would worry about a persistent underperformance in cash creation.
206.80%
Below 50% of ADI's 960.81%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
117.86%
3Y OCF/share CAGR above 1.5x ADI's 14.62%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
161.17%
Net income/share CAGR at 50-75% of ADI's 218.92%. Martin Whitman might question if the firm’s product or cost base lags behind.
748.99%
5Y net income/share CAGR at 75-90% of ADI's 859.96%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
69.80%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
174.56%
10Y equity/share CAGR at 50-75% of ADI's 246.00%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
33.59%
5Y equity/share CAGR above 1.5x ADI's 16.37%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
13.44%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
271.51%
Dividend/share CAGR of 271.51% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
247.95%
Dividend/share CAGR of 247.95% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
281.54%
3Y dividend/share CAGR at 75-90% of ADI's 351.41%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
8.03%
Our AR growth while ADI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
1.06%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.96%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.22%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
-100.00%
We’re deleveraging while ADI stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.18%
Our R&D shrinks while ADI invests at 1.94%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
4.69%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.